Immunoinformatics and Vaccine Development: An Overview

Angus Nnamdi Oli,1 Wilson Okechukwu Obialor,1 Martins Ositadimma Ifeanyichukwu,2,3 Damian Chukwu Odimegwu,4 Jude Nnaemeka Okoyeh,5 George Ogonna Emechebe,6 Samson Adedeji Adejumo,1 Gordon C Ibeanu7 1Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnam...

Full description

Bibliographic Details
Main Authors: Oli AN, Obialor WO, Ifeanyichukwu MO, Odimegwu DC, Okoyeh JN, Emechebe GO, Adejumo SA, Ibeanu GC
Format: Article
Language:English
Published: Dove Medical Press 2020-02-01
Series:ImmunoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/immunoinformatics-and-vaccine-development-an-overview-peer-reviewed-article-ITT
id doaj-c19d0c24af8c439baa0c94997fcc9f7d
record_format Article
spelling doaj-c19d0c24af8c439baa0c94997fcc9f7d2020-11-25T02:04:15ZengDove Medical PressImmunoTargets and Therapy2253-15562020-02-01Volume 9133052112Immunoinformatics and Vaccine Development: An OverviewOli ANObialor WOIfeanyichukwu MOOdimegwu DCOkoyeh JNEmechebe GOAdejumo SAIbeanu GCAngus Nnamdi Oli,1 Wilson Okechukwu Obialor,1 Martins Ositadimma Ifeanyichukwu,2,3 Damian Chukwu Odimegwu,4 Jude Nnaemeka Okoyeh,5 George Ogonna Emechebe,6 Samson Adedeji Adejumo,1 Gordon C Ibeanu7 1Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria; 2Department of Immunology, College of Health Sciences, Faculty of Medicine, Nnamdi Azikiwe University, Anambra, Nigeria; 3Department of Medical Laboratory Science,Faculty of Health Science and Technology, College of Health Sciences, Nnamdi Azikiwe University,Nnewi Campus, Nnewi, Nigeria; 4Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, University of Nigeria Nsukka, Enugu, Nigeria; 5Department of Biology and Clinical Laboratory Science, Division of Arts and Sciences, Neumann University, Aston, PA 19014-1298, USA; 6Department of Pediatrics, Faculty of Clinical Medicine, Chukwuemeka Odumegwu Ojukwu University, Awka, Nigeria; 7Department of Pharmaceutical Science, North Carolina Central University, Durham, NC 27707, USACorrespondence: Angus Nnamdi Oli Email an.oli@unizik.edu.ngAbstract: The use of vaccines have resulted in a remarkable improvement in global health. It has saved several lives, reduced treatment costs and raised the quality of animal and human lives. Current traditional vaccines came empirically with either vague or completely no knowledge of how they modulate our immune system. Even at the face of potential vaccine design advance, immune-related concerns (as seen with specific vulnerable populations, cases of emerging/re-emerging infectious disease, pathogens with complex lifecycle and antigenic variability, need for personalized vaccinations, and concerns for vaccines’ immunological safety -specifically vaccine likelihood to trigger non-antigen-specific responses that may cause autoimmunity and vaccine allergy) are being raised. And these concerns have driven immunologists toward research for a better approach to vaccine design that will consider these challenges. Currently, immunoinformatics has paved the way for a better understanding of some infectious disease pathogenesis, diagnosis, immune system response and computational vaccinology. The importance of this immunoinformatics in the study of infectious diseases is diverse in terms of computational approaches used, but is united by common qualities related to host–pathogen relationship. Bioinformatics methods are also used to assign functions to uncharacterized genes which can be targeted as a candidate in vaccine design and can be a better approach toward the inclusion of women that are pregnant into vaccine trials and programs. The essence of this review is to give insight into the need to focus on novel computational, experimental and computation-driven experimental approaches for studying of host–pathogen interactions and thus making a case for its use in vaccine development.Keywords: immunoinformatics, computational vaccinology, vaccine design, emerging infections, immune system; vaccinologyhttps://www.dovepress.com/immunoinformatics-and-vaccine-development-an-overview-peer-reviewed-article-ITTimmunoinformaticscomputational vaccinologyvaccine designemerging infectionsimmune system)
collection DOAJ
language English
format Article
sources DOAJ
author Oli AN
Obialor WO
Ifeanyichukwu MO
Odimegwu DC
Okoyeh JN
Emechebe GO
Adejumo SA
Ibeanu GC
spellingShingle Oli AN
Obialor WO
Ifeanyichukwu MO
Odimegwu DC
Okoyeh JN
Emechebe GO
Adejumo SA
Ibeanu GC
Immunoinformatics and Vaccine Development: An Overview
ImmunoTargets and Therapy
immunoinformatics
computational vaccinology
vaccine design
emerging infections
immune system)
author_facet Oli AN
Obialor WO
Ifeanyichukwu MO
Odimegwu DC
Okoyeh JN
Emechebe GO
Adejumo SA
Ibeanu GC
author_sort Oli AN
title Immunoinformatics and Vaccine Development: An Overview
title_short Immunoinformatics and Vaccine Development: An Overview
title_full Immunoinformatics and Vaccine Development: An Overview
title_fullStr Immunoinformatics and Vaccine Development: An Overview
title_full_unstemmed Immunoinformatics and Vaccine Development: An Overview
title_sort immunoinformatics and vaccine development: an overview
publisher Dove Medical Press
series ImmunoTargets and Therapy
issn 2253-1556
publishDate 2020-02-01
description Angus Nnamdi Oli,1 Wilson Okechukwu Obialor,1 Martins Ositadimma Ifeanyichukwu,2,3 Damian Chukwu Odimegwu,4 Jude Nnaemeka Okoyeh,5 George Ogonna Emechebe,6 Samson Adedeji Adejumo,1 Gordon C Ibeanu7 1Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria; 2Department of Immunology, College of Health Sciences, Faculty of Medicine, Nnamdi Azikiwe University, Anambra, Nigeria; 3Department of Medical Laboratory Science,Faculty of Health Science and Technology, College of Health Sciences, Nnamdi Azikiwe University,Nnewi Campus, Nnewi, Nigeria; 4Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, University of Nigeria Nsukka, Enugu, Nigeria; 5Department of Biology and Clinical Laboratory Science, Division of Arts and Sciences, Neumann University, Aston, PA 19014-1298, USA; 6Department of Pediatrics, Faculty of Clinical Medicine, Chukwuemeka Odumegwu Ojukwu University, Awka, Nigeria; 7Department of Pharmaceutical Science, North Carolina Central University, Durham, NC 27707, USACorrespondence: Angus Nnamdi Oli Email an.oli@unizik.edu.ngAbstract: The use of vaccines have resulted in a remarkable improvement in global health. It has saved several lives, reduced treatment costs and raised the quality of animal and human lives. Current traditional vaccines came empirically with either vague or completely no knowledge of how they modulate our immune system. Even at the face of potential vaccine design advance, immune-related concerns (as seen with specific vulnerable populations, cases of emerging/re-emerging infectious disease, pathogens with complex lifecycle and antigenic variability, need for personalized vaccinations, and concerns for vaccines’ immunological safety -specifically vaccine likelihood to trigger non-antigen-specific responses that may cause autoimmunity and vaccine allergy) are being raised. And these concerns have driven immunologists toward research for a better approach to vaccine design that will consider these challenges. Currently, immunoinformatics has paved the way for a better understanding of some infectious disease pathogenesis, diagnosis, immune system response and computational vaccinology. The importance of this immunoinformatics in the study of infectious diseases is diverse in terms of computational approaches used, but is united by common qualities related to host–pathogen relationship. Bioinformatics methods are also used to assign functions to uncharacterized genes which can be targeted as a candidate in vaccine design and can be a better approach toward the inclusion of women that are pregnant into vaccine trials and programs. The essence of this review is to give insight into the need to focus on novel computational, experimental and computation-driven experimental approaches for studying of host–pathogen interactions and thus making a case for its use in vaccine development.Keywords: immunoinformatics, computational vaccinology, vaccine design, emerging infections, immune system; vaccinology
topic immunoinformatics
computational vaccinology
vaccine design
emerging infections
immune system)
url https://www.dovepress.com/immunoinformatics-and-vaccine-development-an-overview-peer-reviewed-article-ITT
work_keys_str_mv AT olian immunoinformaticsandvaccinedevelopmentanoverview
AT obialorwo immunoinformaticsandvaccinedevelopmentanoverview
AT ifeanyichukwumo immunoinformaticsandvaccinedevelopmentanoverview
AT odimegwudc immunoinformaticsandvaccinedevelopmentanoverview
AT okoyehjn immunoinformaticsandvaccinedevelopmentanoverview
AT emechebego immunoinformaticsandvaccinedevelopmentanoverview
AT adejumosa immunoinformaticsandvaccinedevelopmentanoverview
AT ibeanugc immunoinformaticsandvaccinedevelopmentanoverview
_version_ 1724943652927569920